Varaico: Literature-Extracted Genetic Variants

Gene:NR2F1
Variant:p.A155T
Back to variants list

NR2F1

NM_005654.6:p.A155T

Associated Papers

The Natural Course of Bosch-Boonstra-Schaaf Optic Atrophy Syndrome.

Valentin I et al.

Clinical Genetics, 2025

A pathogenic NR2F1 gene variant disrupts transcriptional activity and causes severe neurodevelopmental delay in Bosch-Boonstra-Schaaf syndrome.

Liu J et al.

Hereditas, 2025

A fetus with Bosch-Boonstra-Schaaf optic atrophy syndrome characterized by bilateral ventricle widening: A case report and related literature review.

Sun Y et al.

Medicine, 2022

Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome.

Bertacchi M et al.

Cells, 2022

NR2F1 database: 112 variants and 84 patients support refining the clinical synopsis of Bosch-Boonstra-Schaaf optic atrophy syndrome.

Billiet B et al.

Human Mutation, 2022

Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model.

Jurkute N et al.

Brain Communications, 2021

Missense NR2F1 variant in monozygotic twins affected with the Bosch-Boonstra-Schaaf optic atrophy syndrome.

Mio C et al.

Molecular Genetics & Genomic Medicine, 2020

Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome.

Kaiwar C et al.

Cold Spring Harbor Molecular Case Studies, 2017

The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype-phenotype correlations.

Chen CA et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2016

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."